Guiding the design of HQ compounds: predictive ADME modeling and multi-parameter optimization

webinar

Tue, 08 Dec 2015, 17:00 CET (Berlin)

Dr. Matt Segall, CEO Optibrium, UK

Guiding the design of HQ compounds: predictive ADME modeling and multi-parameter optimization

Achieving target potency is not the only goal of lead optimization. To achieve efficacy and avoid safety issues, a high quality drug candidate must have an appropriate profile of absorption, distribution, metabolism and excretion (ADME) properties. Therefore, accurate predictions of these compound properties, while considering new ‘virtual’ compounds, can guide the design process toward compounds that achieve a balance of potency with these other requirements, improving efficiency and reducing the risk of late-stage failures that can cost R&D departments millions of Euros.

In this webinar Dr. Segall, CEO of Opbitrium, will describe the development and validation of quantitative structure-activity relationship (QSAR) models of key ADME properties, such as lipophilicity, solubility, absorption, hERG inhibition and blood-brain barrier penetration. He will consider the confidence in the predictions of such models and how this relates to their domains of applicability.

He will also explore how predictive models can be used as part of a true multi-parameter optimisation environment to select high quality compounds, with an optimal balance of properties, while explicitly considering uncertainties to avoid missed opportunities. Furthermore, the Glowing MoleculeTM visualization highlights regions of a compound with a strong influence on a predicted property, to guide the design of compounds with improved properties. This will be illustrated with Optibrium’s StarDropTM software.

Finally, we will discuss how the approaches of structure-based design and multi-parameter optimisation can be brought together, the focus of the collaboration between Optibrium and BioSolveIT. Dr. Segall will demonstrate how StarDrop’s ADME QSAR models have been integrated within SeeSAR to monitor these properties while considering design strategies in 3D. He will also motivate how SeeSAR will be integrated with StarDrop, to seamlessly link 2D and 3D SAR and identify new strategies for optimisation.

Current news

category
Challenge
Martin Schwalm Emerges as Winner of Scientific Challenge Spring 2023
March 15, 2024 14:44 CET
The Scientific Challenge Spring 2023 comes to a conclusion: Martin Schwalm from the University of Frankfurt wins with his project “Identifying Binders to Hijack the Autophagy System for Targeted Protein Degradation”! The study aimed to identify binders for the LC3A protein’s hydrophobic binding site, a crucial target for drug discovery...
Read on
category
Software
Chemical Space Nagivation CLI Tool Updates
March 12, 2024 15:14 CET
Alongside infiniSee 6 ‘Echo’ we release updates to our command line tools that explore and create Chemical Spaces. Computational and tech-savvy medicinal chemists receive several powerful augmentations to the software; these help fine-tuning search parameters to perform even more efficient screening campaigns. New to those features are the new SMARTS...
Read on
category
Software
infiniSee 6 'Echo' Completes Trinity of Chemical Space Navigation
March 11, 2024 13:36 CET
We are more than proud to complete the trinity of Chemical Space navigation with the release of infiniSee Version 6, codenamed ‘Echo’! With Echo’s debut, a new feature called Motif Matcher has been introduced, enabling the screening of incredibly vast Chemical Spaces for compounds exhibiting high maximum common substructure (MCS)...
Read on